Manulife (Manufacturers Life Insurance)’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,770
Closed -$16K – 3014
2024
Q1
$16K Sell
1,770
-10
-0.6% -$91 ﹤0.01% 2932
2023
Q4
$16.9K Sell
1,780
-99
-5% -$870 ﹤0.01% 2946
2023
Q3
$22.4K Sell
1,879
-1,377
-42% -$24.4K ﹤0.01% 2958
2023
Q2
$79.8K Buy
3,256
+1,193
+58% +$31.1K ﹤0.01% 2918
2023
Q1
$64.6K Hold
2,063
– – ﹤0.01% 2824
2022
Q4
$145K Buy
2,063
+204
+11% +$15.1K ﹤0.01% 2695
2022
Q3
$160K Sell
1,859
-86
-4% -$8.36K ﹤0.01% 2678
2022
Q2
$161K Buy
1,945
+487
+33% +$43K ﹤0.01% 2755
2022
Q1
$242K Sell
1,458
-248
-15% -$35.6K ﹤0.01% 2643
2021
Q4
$285K Buy
1,706
+270
+19% +$30.5K ﹤0.01% 2638
2021
Q3
$124K Buy
+1,436
New +$95K ﹤0.01% 3089
2021
Q2
– Sell
-2,114
Closed -$126K – 3255
2021
Q1
$126K Sell
2,114
-222
-10% -$13K ﹤0.01% 3018
2020
Q4
$122K Buy
2,336
+525
+29% +$29.2K ﹤0.01% 2923
2020
Q3
$88K Buy
1,811
+95
+6% +$4.54K ﹤0.01% 2821
2020
Q2
$94K Buy
1,716
+363
+27% +$18.3K ﹤0.01% 2771
2020
Q1
$59K Buy
+1,353
New +$55K ﹤0.01% 2710

Other funds holding KZR

Manulife (Manufacturers Life Insurance)'s KZR Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 1,770 shares — an estimated $16K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $285K in Q4 2021. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,770 Kezar Life Sciences shares in Q2 2024, an estimated $16K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Kezar Life Sciences position peaked at $285K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.